Ligand · 0Q4
0Q4 · N-[(2R)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide
0Q4, N-[(2R)-2-({N~5~-[amino(iminio)methyl]-L-ornithyl-L-valyl}amino)-4-methylpentyl]-L-phenylalanyl-L-alpha-glutamyl-L-alanyl-L-norleucinamide (C40 H70 N11 O8 +1, 833.0 g/mol), in the MolNFT structures on GenesisL1: bound in 3 records (3…
- Component
- 0Q4
- Formula
- C40 H70 N11 O8 +1
- Class
- ligand
- Structures
- 3
- PDB entries
- 3
Binding sites
0Q4 in 3 structures; the first of them:
- 5KQZ · Protease E35D-CaP2 · 0Q4 B101 · binds ARG8, LEU23, ASN25, GLY27, ALA28, ASP29, ASP30, VAL32 and 29 more
- 6O48 · Wild-type HIV-1 protease in complex with a substrate analog CA-p2 · 0Q4 B201 · binds ARG8, LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, VAL32 and 28 more
- 6O5X · Crystal Structure of multi-drug resistant HIV-1 protease PR-S17 with substrate analog… · 0Q4 B101 · binds ARG8, LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, VAL32 and 28 more
Residues it binds most
ILE 4, ASP 4, GLY 4, VAL 4, LEU 4, ALA 4, ARG 4, PRO 4, LYS 4, SER 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.